Paw-sitive Results: PetMed Express Delivers Earnings Surprise in Q4 Report

In a quarter that many companies would rather forget, PetMed Express, Inc. (NASDAQ: PETS) has managed to wag its tail with an impressive earnings report for the fourth quarter of fiscal 2020. While the world was grappling with the unprecedented impact of COVID-19, PetMed saw its net sales jump by 15%, bringing in a hefty $74.3 million compared to $64.6 million during the same period last year. It seems the pet pharmacy is not just barking up the right tree, but has found a whole grove of revenue in these challenging times.

EPS and Earnings Surprise

Not only did PetMed achieve a commendable revenue forecast, but it also reported an earnings surprise that left some analysts scratching their heads. The company?s earnings per share (EPS) rose to $0.35, an 8.4% increase from the $0.32 EPS consensus of the prior year. This performance demonstrates that, even in turbulent times, PetMed is agile enough to adapt and thrive, proving the resilience of their eCommerce model as consumer habits shift toward online purchasing.

New Customers and Order Trends

In addition to increased sales, PetMed acquired approximately 107,000 new customers in the quarter. This is up from 101,000 during the same period last year, illustrating a growing interest in their services. New order sales also saw a modest increase of 5%, reaching $9.1 million, which signals that consumers are not just sticking around but are also willing to spend more on their furry friends? health needs. The average order size climbed to $90 from $85?proof that when it comes to pet care, customers are ready to open their wallets.

CEO Insights and Future Outlook

Menderes Akdag, President and CEO, commented on the changing landscape: ?During the March quarter, due to COVID-19, demand has been strong for the eCommerce channel, with consumers shifting their purchases online.? This pivot to digital has proven beneficial for PetMed, allowing the company to optimize its advertising strategies effectively. Akdag?s commitment to ensuring that pets receive their medications during these trying times highlights the company's dedication not just to profits, but to pet welfare?an increasingly important factor for consumers today.

Dividend Increase: A Treat for Shareholders

And for those shareholders looking for a little extra tail-wagging, PetMed has declared an increased quarterly dividend, raising it from $0.27 to $0.28 per share. This dividend will be payable on May 22, 2020, to shareholders of record by May 15, showing that PetMed remains committed to rewarding its investors even amidst uncertainty. However, as always, future dividends will be at the discretion of the Board of Directors, who will assess the financial performance each quarter.

Looking Ahead: The Competitive Landscape

As PetMed Express continues to adapt to the changing market dynamics, it is essential to consider how this may affect its peers in the pet care and pharmacy industry. With the eCommerce sector booming, other companies must take heed of PetMed?s strategies?particularly the emphasis on customer acquisition and online sales. The pet care market is expected to grow, but it will be those who can pivot their business models effectively that will thrive.